Johnson & Johnson to Buy Halda Therapeutics For .05 Billion
1 min read

Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion

farman.mansoori.ff@gmail.com0


Johnson & Johnson has agreed to buy clinical-stage biotechnology company Halda Therapeutics for $3.05 billion in cash in a deal that bolsters the healthcare giant’s oncology pipeline.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Website http://newswave.blog

Related Posts